- Home
- ORGO vs TTI Comparison
ORGO vs TTI Comparison
Compare ORGO & TTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- TTI
- Stock Information
- Founded
- ORGO 1985
- TTI 1981
- Country
- ORGO United States
- TTI United States
- Employees
- ORGO N/A
- TTI N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- TTI Oil & Gas Production
- Sector
- ORGO Health Care
- TTI Energy
- Exchange
- ORGO Nasdaq
- TTI Nasdaq
- Market Cap
- ORGO 533.9M
- TTI 467.4M
- IPO Year
- ORGO N/A
- TTI 1990
- Fundamental
- Price
- ORGO $5.34
- TTI $2.93
- Analyst Decision
- ORGO Buy
- TTI Strong Buy
- Analyst Count
- ORGO 2
- TTI 3
- Target Price
- ORGO $5.50
- TTI $6.17
- AVG Volume (30 Days)
- ORGO 1.7M
- TTI 1.8M
- Earning Date
- ORGO 05-08-2025
- TTI 04-29-2025
- Dividend Yield
- ORGO N/A
- TTI N/A
- EPS Growth
- ORGO N/A
- TTI 426.72
- EPS
- ORGO N/A
- TTI 0.84
- Revenue
- ORGO $482,043,000.00
- TTI $605,279,000.00
- Revenue This Year
- ORGO $3.31
- TTI $8.58
- Revenue Next Year
- ORGO $12.50
- TTI $10.67
- P/E Ratio
- ORGO N/A
- TTI $3.49
- Revenue Growth
- ORGO 11.29
- TTI N/A
- 52 Week Low
- ORGO $2.17
- TTI $2.03
- 52 Week High
- ORGO $6.71
- TTI $5.12
- Technical
- Relative Strength Index (RSI)
- ORGO 67.16
- TTI 55.48
- Support Level
- ORGO $5.14
- TTI $2.60
- Resistance Level
- ORGO $5.42
- TTI $3.06
- Average True Range (ATR)
- ORGO 0.28
- TTI 0.18
- MACD
- ORGO 0.09
- TTI 0.07
- Stochastic Oscillator
- ORGO 85.09
- TTI 77.85
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About TTI Tetra Technologies Inc.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.